A recall of its baby powder sparked worries about the healthcare giant's asbestos-related legal battles.
Plans to launch cannabis-infused beverages lit a fire beneath the beaten-down marijuana stock.
A potentially large new cannabis market is at hand in Canada. Here's what to look for.
Investors are excited about the potential for a settlement in opioid litigation.
Here's a quick rundown on how the healthcare giant performed.
Which stock wins in a one-on-one matchup between a leading Canadian cannabis producer and a top e-commerce company serving the cannabis industry?
It's growing. It's profitable. It's beating expectations. The other big Canadian pot stocks aren't.
Impressive quarterly results are lighting a fire beneath this Canadian marijuana stock.
All three of these top Canadian marijuana stocks are struggling. But a Jefferies analyst thinks that two out of three of them aren't bad.
MedMen says its approach is to go deep rather than wide now that the PharmaCann buyout has been scrapped.
Investors' anxiety about forthcoming earnings results appeared to weigh on the Canadian marijuana stock.
Winter is coming. But these hot stocks should keep on sizzling.
This medical innovator is quietly working on artificial intelligence technology that could pay off nicely for investors.
High dividend yields. Solid long-term prospects. These stocks have exactly what retired investors are looking for.
You don't have to be a billionaire to profit from these great stocks.
The two biggest Canadian cannabis producers might not be able to sweep this problem under the rug.
This high-growth company just officially entered the CBD market. And that makes its stock an even more intriguing alternative for investors.
Which stock wins in a battle between these two big drugmakers?
Which stock wins in a matchup between a top ancillary provider to the cannabis industry and a small Canadian cannabis producer?
Hint: It's not the cannabis producer's disappointing Q4 revenue or the unexpected departure of its CFO.